Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NSCLC: Final results from the non-interventional study NADIR 5. November 2020 C Geßner, A Lück, H Schulz, C Losem, G Dresemann, S Grebhardt, J Harde, N Marschner, J Hipp, K Potthoff, 2020 Oncol Res Treat. 2020;43(suppl 4)(200):327 https://www.iomedico.com/wp-content/uploads/2020/11/Gessner_DGHO_Nadir.mp4 Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations – Special focus on KRAS G12C Griesinger F, Eberhardt WEE, Hoffnecht P, Metzenmacher M, Wehler T, Kokowski K, Alt J, Schütte W, Jänicke M, Fleitz A, Zacharias S, Hipper A, Buller… Weiterlesen Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with SCLC: final results from the non-interventional study NADIR Losem C, Maintz C, Schulz H, Lück A, Geßner C, Grebhardt S, et al. Oncol Res Treat. 2020;43(suppl 4)(200):328 https://www.iomedico.com/wp-content/uploads/2020/11/Potthoff_NADIR_DGHO2020.mp4… Weiterlesen